Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study-Reference-Cited by-同舟云学术

Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study

Published:2023-12-28 Issue:8S Volume:22 Page:3793
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Balanova Yu. A.¹^ORCID,Drapkina O. M.¹^ORCID,Kutsenko V. A.²^ORCID,Imaeva A. E.¹^ORCID,Kontsevaya A. V.¹^ORCID,Maksimov S. A.¹^ORCID,Muromtseva G. A.¹^ORCID,Kotova M. B.¹^ORCID,Karamnova N. S.¹^ORCID,Evstifeeva S. E.¹^ORCID,Kapustina A. V.¹^ORCID,Litinskaya O. A.¹^ORCID,Pokrovskaya M. S.¹^ORCID,Kuzyakina S. O.¹^ORCID,Ivlev O. E.¹^ORCID,Gomanova L. I.¹^ORCID,Doludin Yu. V.¹^ORCID,Efimova I. A.¹^ORCID,Borisova A. L.¹^ORCID,Nazarov B. M.³^ORCID,Yarovaya E. B.²^ORCID,Repkina T. V.⁴^ORCID,Gonoshilova T. O.⁴^ORCID,Kudryavtsev A. V.⁵^ORCID,Belova N. I.⁵^ORCID,Shagrov L. L.⁵^ORCID,Samotrueva M. A.⁶^ORCID,Yasenyavskaya A. L.⁶^ORCID,Chernysheva E. N.⁶^ORCID,Glukhovskaya S. V.⁷^ORCID,Levina I. F.⁷^ORCID,Shirshova T. F.⁷^ORCID,Dorzhieva E. B.⁸^ORCID,Urbanova E. Z.⁸^ORCID,Borovkova N. Yu.⁹^ORCID,Kurashin V. K.⁹^ORCID,Tokareva A. S.⁹^ORCID,Ragino Yu. I.¹⁰^ORCID,Simonova G. I.¹⁰^ORCID,Khudyakova A. D.¹⁰^ORCID,Nikulin V. N.¹¹^ORCID,Aslyamov O. R.¹¹^ORCID,Khokhlova G. V.¹¹^ORCID,Solovyova A. V.¹²^ORCID,Rodionov A. A.¹²^ORCID,Kryachkova O. V.¹²^ORCID,Shamurova Yu. Yu.¹³^ORCID,Tantsyreva I. V.¹³^ORCID,Baryshnikova I. N.¹³^ORCID,Ataev M, G.¹⁴^ORCID,Radjabov M. O.¹⁴^ORCID,Isakhanova M. M.¹⁴^ORCID,Umetov M. A.¹⁵^ORCID,Elgarova L. V.¹⁵^ORCID,Khakuasheva E. A.¹⁵^ORCID,Yamashkina E. I.¹⁶^ORCID,Esina M. V.¹⁶^ORCID,Kunyaeva T. A.¹⁷^ORCID,Nikitina A. M.¹⁸^ORCID,Savvina N. V.¹⁹^ORCID,Spiridonova Yu. E.¹⁸^ORCID,Naumova E. A.²⁰^ORCID,Keskinov A. A.²¹^ORCID,Yudin V. S.²¹^ORCID,Yudin S. M.²¹^ORCID,Shalnova S. A.¹^ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

2. National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University

3. City Polyclinic № 109

4. Regional Center for Public Health and Medical Prevention

5. Northern State Medical University

6. Astrakhan State Medical University

7. Sverdlovsk Regional Medical College

8. Boyanov Center for Public Health and Medical Prevention

9. Privolzhsky Research Medical University

10. Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics

11. Orenburg Regional Center for Public Health and Medical Prevention

12. Tver State Medical University

13. South Ural State Medical University

14. Abusuev Research Institute of Environmental Medicine, Dagestan State Medical University

15. Berbekov Kabardino-Balkarian State University

16. Ogarev Mordovian State University

17. Ogarev Mordovian State University; Mordovian Republican Central Clinical Hospital

18. Republican Center for Public Health and Medical Prevention

19. Ammosov North-Eastern Federal University

20. Republican Center for Public Health and Medical Prevention, Exercise therapy and Sports Medicine

21. Center for Strategic Planning and Management of Biomedical Health Risks

Abstract

Aim. To study the problem of obesity at the national level.Material and methods. The ESSE-RF3 study examined a representative sample of the population of 15 Russian regions aged 35-74 years with a response >70% (n=28731). Modular design questionnaire was used. The study received approval from the Independent Ethics Committee of the National Medical Research Center for Therapy and Preventive Medicine. Signed informed consent was obtained from each participant. Body mass (BM) was measured once with an accuracy of 100 g. The height was measured with an accuracy of 0,5 cm once in a standing position without shoes. Waist circumference was measured with a standard measuring tape with an accuracy of 0,5 cm. There were following BM categories: insufficient (BM index (BMI) <18,5), normal (18,5≲ BMI ≲24,9), overweight (25,0≲ BMI ≲29,9), class I obesity (30,0≲ BMI ≲34,9), class II obesity (35,0≲ BMI ≲39,9) and class III obesity (BMI >40). Abdominal obesity (AO) was assessed using the following criteria: waist circumference ≥102 cm and ≥88 cm for men and women, respectively. The changes of obesity were studied with the inclusion of materials from the ESSE-RF (2012-14) and ESSE-RF2 (2017) studies, carried out using the same methodology with ESSE-RF3 in the same age range of 35-64 years. Statistical analysis was carried out using the open-source R 3.6.1 environment. Analysis of associations between factors and a binary variable was carried out using the logistic regression method. The significance level for all tested hypotheses was 0,05.Results. Mean BMI values is 28,2±4,6 kg/m2 among men and 28,9±5,9 kg/m2 among women. The prevalence of overweight is 44,0 and 33,7%, obesity — 30,0 and 39,5%, AO — 30,9 and 55,1% among men and women, respectively. In addition, 30,3% have a combination of obesity and AO; obesity and/or AO — 49,1%. Obesity statistics did not significantly change, but in each section the rates are higher among women. The closest associations were found between obesity and hypertension (men: odds ratio (OR) (95% confidence interval) 2,88 (2,66-3,12), women: OR 3,03 (2,81-3,27) (p<0,001) and hyperuricemia for women (OR 4,21 (3,74-4,75) (p<0,001).Conclusion. A third of the Russian population is obese, and half has obesity and/or AO. This severity of the problem requires the development and adoption of a strategy to monitor obesity at the national level.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine,Education

Reference20 articles.

1. Wang Y, Beydoun MA, Min J, et al. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020;49(3):810-23. doi:10.1093/IJE/DYZ273.

2. Ma S, Xi B, Yang L, et al. Trends in the prevalence of overweight, obesity, and abdominal obesity among Chinese adults between 1993 and 2015. Int J Obes. 2021;45:427-37. doi:10.1038/s41366-020-00698-x.

3. Okati-Aliabad H, Ansari-Moghaddam A, Kargar S, Jabbari N. Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis. J Obes. 2022;2022:8074837, 18 p. doi:10.1155/2022/8074837.

4. Shalnova SA, Deev AD, Kapustina AV, et al. Body weight and its impact on all-cause and cardiovascular mortality in Russia. Cardiovascular Therapy and Prevention. 2014;13(1):44-8. (In Russ.) doi:10.15829/1728-8800-2014-1-44-48.

5. Abohashem S, Sayed A, Aldosoky W, et al. Burden and disparities in cardiovascular mortality rates associated with obesity prevalence in United States: county-level analysis from 2010 to 2019. Eur Heart J. 2022;43(2):2398. doi:10.1093/EURHEARTJ/EHAC544.2398.